The impact of age and CYP2C9 and VKORC1 variants on stable warfarin dose in the paediatric population.
Vear, Susan I; Ayers, Gregory D; Van Driest, Sara L; Sidonio, Robert F; Stein, Charles Michael; Ho, Richard H.
Br J Haematol
; 165(6): 832-5, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24601977
[Verification of accuracy of warfarin stable dose prediction models in Shandong population].
Verification of pharmacogenomics-based algorithms to predict warfarin maintenance dose using registered data of Japanese patients.
Pharmacogenetics of warfarin in a paediatric population: time in therapeutic range, initial and stable dosing and adverse effects.
Interpretation of the effect of CYP2C9, VKORC1 and CYP4F2 variants on warfarin dosing adjustment in Turkey.
Influence of Genotype on Warfarin Maintenance Dose Predictions Produced Using a Bayesian Dose Individualization Tool.
Effect of VKORC1 and CYP2C9 polymorphisms on warfarin dose requirement in Bangladeshi population.
Nutri-pharmacogenomics of warfarin anticoagulation therapy: VKORC1 genotype-dependent influence of dietary vitamin K intake.
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon.
Identification of gene modules associated with warfarin dosage by a genome-wide DNA methylation study.
A pharmacogenetic versus a clinical algorithm for warfarin dosing.